Catalyst Wire Dossier Catalyst Wire Dossier

mobocertinib

mobocertinib · Millennium Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for mobocertinib, covering 2021-07-30 to 2024-01-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy Kidneys [Phase 1]

See pricing